Cardiff Oncology, Inc. (CRDF)

[briphelps]

Liquid Biopsy Technology By William Patalon III, Executive Editor, Money Morning • June 23, 2016
Look Who's Talking… About Liquid Biopsy Technology

By William Patalon III, Executive Editor, Money Morning • June 23, 2016

William Patalon III

I've told this story before, but it bears repeating here...

Back in April 2015, about a month after I originally recommended "Liquid Biopsy" stock TrovaGene Inc. (Nasdaq: TROV), biotech-sector executive Tina Nova wrote in a Wired magazine essay that the still-in-development cancer-screening technology is "the most exciting thing I've seen since I started my career."

This is premium content for Private Briefing subscribers only.

As the executive editor of Money Morning, Bill Patalon has perfected a secret investment strategy that could help you put an extra $125K into your portfolio - this year. To date, Bill has used this strategy to pick 257 winning investments, including 192 double- and triple-digit peak gains. Once you see the secret, you'll immediately understand why it works so well.